TY  - GEN
DO  - 10.4337/qmjip.2022.01.06
DO  - doi
T1  - Supplemental experimental data in Chinese pharmaceutical patent practice:acceptable or not? /
DA  - 2022
CY  - Edward Elgar Publishing Ltd.
AU  - Han, Weiwei.
JF  - Queen Mary Journal of Intellectual Property
VL  - 12, 1, 2022, pp. 110-134.
PP  - Edward Elgar Publishing Ltd.
LA  - eng
PY  - 2022
ID  - 45946
KW  - Health Industry.
KW  - Pharmaceuticals.
SN  - Online: 2045-9815
TI  - Supplemental experimental data in Chinese pharmaceutical patent practice:acceptable or not? /
LK  - https://www.elgaronline.com/view/journals/qmjip/12-1/qmjip.2022.01.06.xml
UR  - https://www.elgaronline.com/view/journals/qmjip/12-1/qmjip.2022.01.06.xml
ER  -